The Agency for Science, Technology and Research (A*STAR) and the National University of Singapore (NUS) launched a joint synthetic biology commercialisation laboratory [1].

The facility aims to reduce global reliance on petrochemical-based production by creating sustainable alternatives for common industrial ingredients. This shift targets the environmental impact of traditional chemical manufacturing by leveraging biological systems to create materials.

Based in Singapore, the laboratory will focus on the use of engineered microbes and enzymes [1]. These biological tools allow companies to produce chemicals, materials, and ingredients through processes that are more sustainable than conventional methods [2].

The initiative specifically targets the production of everyday consumer goods. This includes the sustainable manufacture of fragrances, vitamins, and fats [1]. By moving away from petrochemical processes, the lab seeks to lower the carbon footprint associated with these widely used products [2].

The partnership between A*STAR and NUS combines government-led research with academic expertise to accelerate the commercialisation of synthetic biology. The lab serves as a bridge for companies to transition from laboratory-scale biological discoveries to industrial-scale production [2].

Synthetic biology involves redesigning organisms for useful purposes by engineering them to have new abilities. In this context, the lab focuses on optimizing these organisms to act as microscopic factories, producing complex molecules that were previously derived from oil and gas [1].

“The laboratory will focus on the use of engineered microbes and enzymes.”

This collaboration signals a strategic shift in Singapore's industrial policy toward 'green chemistry.' By integrating academic research from NUS with A*STAR's commercialisation framework, the city-state is attempting to decouple the production of essential chemicals from fossil fuel volatility and environmental degradation.